CONNECTA Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3.6M

  • Investors
  • 9

CONNECTA Therapeutics General Information

Description

Operator of a biotechnology company intended to develop new treatments for central nervous system disorders. The company researches and develops molecules for neuroplasticity-mediated disorders with social behavior and pro-cognitive properties, enabling healthcare and medical professionals to provide treatment for X syndrome to patients.

Contact Information

Website
www.connectatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Parc Científic de Barcelona
  • Baldiri Reixac, Number 10-12
  • 08028 Barcelona
  • Spain
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, Digital Health, Life Sciences
Corporate Office
  • Parc Científic de Barcelona
  • Baldiri Reixac, Number 10-12
  • 08028 Barcelona
  • Spain

CONNECTA Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CONNECTA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 10-Sep-2026 $3.6M Completed Clinical Trials - Phase 2
8. Debt - General Completed Clinical Trials - Phase 2
7. Grant 09-Sep-2025 Completed Clinical Trials - Phase 2
6. Grant 02-Dec-2024 Completed Clinical Trials - Phase 2
5. Debt - General 06-Jun-2023 Completed Clinical Trials - Phase 1
4. Seed Round 21-Mar-2023 Completed Clinical Trials - Phase 1
3. Seed Round 14-Oct-2022 Completed Pre-Clinical Trials
2. Grant 03-Feb-2022 $280K $2.01M Completed Pre-Clinical Trials
1. Seed Round 26-Sep-2020 $2.01M $2.01M Completed Pre-Clinical Trials
To view CONNECTA Therapeutics’s complete valuation and funding history, request access »

CONNECTA Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
To view CONNECTA Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CONNECTA Therapeutics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

CONNECTA Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026013142-A2 Compounds and compositions for the treatment of nervous system disorders Pending 10-Jul-2024
WO-2026013142-A3 Compounds and compositions for the treatment of nervous system disorders Pending 10-Jul-2024
FR-2322437-A1 Flat electric cable and process as well as a machine for the manufacture of such cables Active 09-Mar-1973
GB-1458065-A Flat electrical cables and methods and machines for producing such cables Inactive 09-Mar-1973 H01B7/0838

CONNECTA Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CONNECTA Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clave Capital Hedge Fund Minority
European Innovation Council Accelerator/Incubator Minority
European Union Government
CDTI Innvierte Government Minority
Inicio - Ministerio de Ciencia, Innovación y Universidades Government
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

CONNECTA Therapeutics FAQs

  • When was CONNECTA Therapeutics founded?

    CONNECTA Therapeutics was founded in 2019.

  • Where is CONNECTA Therapeutics headquartered?

    CONNECTA Therapeutics is headquartered in Barcelona, Spain.

  • What is the size of CONNECTA Therapeutics?

    CONNECTA Therapeutics has 8 total employees.

  • What industry is CONNECTA Therapeutics in?

    CONNECTA Therapeutics’s primary industry is Drug Discovery.

  • Is CONNECTA Therapeutics a private or public company?

    CONNECTA Therapeutics is a Private company.

  • What is CONNECTA Therapeutics’s current revenue?

    The current revenue for CONNECTA Therapeutics is .

  • How much funding has CONNECTA Therapeutics raised over time?

    CONNECTA Therapeutics has raised $8.01M.

  • Who are CONNECTA Therapeutics’s investors?

    Clave Capital, European Innovation Council, European Union, CDTI Innvierte, and Inicio - Ministerio de Ciencia, Innovación y Universidades are 5 of 9 investors who have invested in CONNECTA Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process